Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Lenka Vostalová"'
Autor:
Krzysztof Piotr Malinowski, Paweł Kawalec, Wojciech Trąbka, Marcin Czech, Guenka Petrova, Manoela Manova, Alexandra Savova, Pero Draganić, Lenka Vostalová, Juraj Slabý, Agnes Männik, Kristóf Márky, Zinta Rugaja, Jolanta Gulbinovic, Tomas Tesar, Marian Sorin Paveliu
Publikováno v:
Frontiers in Pharmacology, Vol 10 (2019)
BackgroundReimbursement policies influence access of patients to orphan drugs in the European countries.ObjectivesTo provide a comprehensive description of orphan drug reimbursement policies and to assess reimbursement decision-making process in the
Externí odkaz:
https://doaj.org/article/0060948c11e742faa55b2b79d100a3a7
Publikováno v:
International Journal of Technology Assessment in Health Care. 33:339-344
Objectives: In the Czech Republic, the health technology assessment (HTA) approaches have been implemented in evaluation of medicinal products since 2008.The aim of this study was to provide an overview of the implementation of HTA and different leve
Autor:
Malinowski, Krzysztof Piotr, Kawalec, Paweł, Trąbka, Wojciech, Czech, Marcin, Petrova, Guenka, Manova, Manoela, Savova, Alexandra, Draganić, Pero, Vostalová, Lenka, Slabý, Juraj, Männik, Agnes, Márky, Kristóf, Rugaja, Zinta, Gulbinovic, Jolanta, Tesar, Tomas, Paveliu, Marian Sorin
Publikováno v:
Frontiers in Pharmacology; 5/8/2019, pN.PAG-N.PAG, 16p
Autor:
Malinowski, Krzysztof Piotr1 (AUTHOR) krzysztof.malinowski@doctoral.uj.edu.pl, Kawalec, Paweł1 (AUTHOR), Trąbka, Wojciech2 (AUTHOR), Sowada, Christoph1 (AUTHOR), Petrova, Guenka3 (AUTHOR), Manova, Manoela3,4 (AUTHOR), Savova, Alexandra3,4 (AUTHOR), Draganić, Pero5,6 (AUTHOR), Slabý, Juraj7 (AUTHOR), Männik, Agnes8 (AUTHOR), Márky, Kristóf9 (AUTHOR), Rugaja, Zinta10 (AUTHOR), Gulbinovic, Jolanta11 (AUTHOR), Tesar, Tomas12 (AUTHOR), Paveliu, Marian Sorin13 (AUTHOR)
Publikováno v:
Orphanet Journal of Rare Diseases. 10/8/2020, Vol. 15 Issue 1, pN.PAG-N.PAG. 1p.
Publikováno v:
International Journal of Technology Assessment in Health Care; Aug2017, Vol. 33 Issue 3, p339-344, 6p
Autor:
Andrea Parziale
This book examines the regulatory framework for untested and unapproved uses (off-label uses) of medicines in the EU, UK, and USA. Before reaching patients, medicines are extensively tested by manufacturers and approved by regulators to minimise the